Lehrer-Graiwer Joshua 4
4 · Global Blood Therapeutics, Inc. · Filed Mar 9, 2020
Insider Transaction Report
Form 4
Lehrer-Graiwer Joshua
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-03-05$65.30/sh−1,138$74,311→ 2,595 total - Sale
Common Stock
2020-03-09$59.90/sh−938$56,186→ 2,595 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-03-09−938→ 1,875 totalExercise: $19.89Exp: 2026-09-07→ Common Stock (938 underlying) - Exercise/Conversion
Common Stock
2020-03-09$19.89/sh+938$18,657→ 3,533 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold ranging from $59.80 to $60.00 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from September 8, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.